An interventional study of Imaging with 18F-FLT PET and Imaging with 18F-FLT PET in CNS Brain Metastasis, Head and Neck Cancer and Lung Cancer, sponsored by University of Wisconsin, Madison. Terminated at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-02-23.
Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Treatment
Fractionated radiotherapy induces an observable change in the proliferative activity as assessed by pre-treatment and early-treatment 18F-FLT PET imaging. This study is designed to investigate 18F-FLT as a PET imaging agent for predicting treatment effectiveness in several tumors and will serve as a pilot study to a planned PO1 submission
1,960 studies on the registry are indexed under Brain Neoplasms; 516 are open to participants now.
This study's enrollment of 15 is below the median of 40 across 1,458 interventional studies indexed under Brain Neoplasms.
Browse Brain Neoplasms studies →University of Wisconsin, Madison is the lead sponsor of 1,161 studies on the registry; 182 are open to participants now.
Of its 151 completed or terminated interventional studies of FDA-regulated products, 114 (75%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Imaging with 18F-FLT PET
Procedure: Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Procedure: Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Procedure: Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Procedure: Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Procedure: Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
Imaging with 18F-FLT PET
To test whether the cellular response to fractionated radiotherapy leads to observable global change in the uptake of 18F-FLT as assessed by PET imaging
Time frame: end of study
To assess the technical and logistic feasibility of 18F-FLT scans in a population of cancer patients
Time frame: end of study
This study is terminated, as verified in Feb 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Wisconsin, Madison